By GREGORY ZELLER // If ever there was a can’t-miss 21st Century business proposition, un-hackable communications networks just might be it. Ultra-secure networking is a rock-solid concept with vast potential…
By GREGORY ZELLER // Several breakout research projects – and a few familiar faces from the cutting edge – scored funding this week through Stony Brook University’s annual biotechnology awards…
By GREGORY ZELLER // Two of Long Island’s most-promising biotech startups are packing up their R&D and heading for greener pastures. At least for now. Symbiotic Health and Goddard Labs…
No, she’s not related to rocketing pioneer Robert Goddard. Besides a surname, she has nothing in common with former OSI Pharmaceuticals CEO Colin Goddard (though she’s a fan). And her…
By GREGORY ZELLER // A spinoff of the Feinstein Institute for Medical Research has snagged a critical $100,000 stake from Accelerate Long Island and the Long Island Emerging Technologies Fund…
By GREGORY ZELLER // Researchers battling the insidious clostridium difficile infection are making progress on several new fronts, including a novel “poop pill” developed by Symbiotic Health, a spinoff from North…